• Medycyna
  • 17 maja
  • FDA to approve Daiichi Sankyo & AstraZeneca's Enhertu
    2
  • 6 października
  • Eli Lilly licenses Peptron's SmartDepot by October 7
    2
  • 30 grudnia
  • CDC to issue Level 3 warning by December 31
    2
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2